SAN JOSE, Calif., Oct. 11 /PRNewswire-USNewswire/ -- Canary Foundation, a nonprofit organization that funds research in early cancer detection, today announced that its founder and chairman, Don Listwin, has been elected to the National Cancer Institute's Board of Scientific Advisors (BSA). Members are appointed to 5-year terms by the National Cancer Institute (NCI) Director. The 35-member board provides advice on science program policy, programs and initiatives to the NCI, the Director and Deputy Director for Extramural Science, and Directors of each NCI Divisions.
"It is a tremendous honor to serve at the NCI with colleague, Dr. Sanjiv Sam Gambhir and with so many leading authorities from various medical and administrative disciplines," said Don Listwin. "I look forward to being able to support the NCI and its important research initiatives."
Don Listwin founded Canary Foundation in 2004 as the world's first non-profit organization dedicated solely to the funding, discovery, and development of tests for early cancer detection. He has since committed his time, energy, expertise, and professional network to build a non-profit organization that will succeed at the creation of an early warning system for cancer. Together, Listwin Family Foundation and Canary Foundation have pledged over 50 million dollars towards early detection cancer research.
Today, Canary has raised nearly $30 million for early detection and has an established Science Team composed of the nation's most innovative researchers. Most recently, Canary formed a strategic partnership with Stanford University to establish the Canary Center for Cancer Early Detection at Stanford, a first-of-its-kind facility that combines in-vitro and in-vivo strategies to enhance future cancer detection and patient management.
"Don's appointment to the Board of Scientific Advisors of the NCI is a fitting testimony to the vital work he has done on behalf of cancer early detection through the Canary Foundation. His new role at the national level will greatly facilitate our efforts as cancer researchers and physicians to improve cancer outcomes through early detection of disease," said Dr. Beverly Mitchell, Director of Cancer Center at Stanford and Professor of Medicine-Oncology.
"I am extremely excited and enthusiastic that Don will join the NCI Board of Scientific Advisors," said Dr. Sanjiv Sam Gambhir. "Having Don's passion, enthusiasm and knowledge on the board will be very valuable as we build and implement a strategic vision at the national level to solve the cancer problem."
"Don Listwin brings to the Board of Scientific Advisors a deep knowledge of business, coupled with a passion driven by the cancer battles of loved ones," said NCI Director John E. Niederhuber, M.D. "In addition, because of his leadership of the Canary Foundation, Don brings to the table knowledge about the funding and management of cancer science. His combination of skills and experience will be invaluable."
About Canary Foundation
Canary Foundation is a non-profit dedicated to the goal of identifying cancer early through a simple blood test and then isolating it with imaging. Since 2004, Canary has raised over $30 million to support early detection research. Its collaborative research programs span multiple disciplines and institutions. One hundred percent of donations go to early detection research activities. For more information, please visit www.canaryfoundation.org.
SOURCE Canary Foundation
|SOURCE Canary Foundation|
Copyright©2009 PR Newswire.
All rights reserved